PT  - JOURNAL ARTICLE
ED  - ,
TI  - Correction: <em>Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial</em>
AID  - 10.1136/jitc-2021-002568corr1
DP  - 2021 Aug 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e002568corr1
VI  - 9
IP  - 8
4099  - http://jitc.bmj.com/content/9/8/e002568corr1.short
4100  - http://jitc.bmj.com/content/9/8/e002568corr1.full
SO  - J Immunother Cancer2021 Aug 01; 9